We have extremely exciting evidence from the initial award period of Project 1 that hepatic insulin resistanceis the major defect in glucose homeostasis associated with the PCOS susceptibility variant. This variant,allele 8 (A8) of the dinucleotide repeat D19S884, was mapped to intron 55 of the fibrillin-3 gene as part ofProject 2 of this SCOR. Male first-degree relatives with the A8 variant have evidence for abnormalities ininsulin secretion suggesting that the metabolic phenotypes associated with the A8 variant are sex-specific.The central hypothesis of the NU SCOR is that hyperandrogenemia resulting from variation in a gene(s)regulating steroidogenesis causes the PCOS metabolic phenotype by programming actions at critical periodsof development as well as by ongoing actions in the adult. We will plan three Specific Aims: 1. To test thehypothesis that hepatic glucose homeostasis differs by A8 genotype in women with PCOS. Postabsorptivehepatic glucose homeostasis, including rates of gluconeogenesis and glycoge no lysis, will be assessed withstate-of-the-art stable isotope techniques. Responses to stimuli that modulate hepatic glucose production,such as glucagon, hypoglycemia and glucose per se, will be examined. 2. To test the hypothesis thatandrogens alter hepatic glucose homeostasis, directly or by antagonizing estrogen action, in women withPCOS and that this action differs by A8 genotype. The impact of blocking androgen action with the nonsteroidalreceptor antagonist, flutamide, alone and during transdermal estradiol replacement, will beinvestigated. Endpoints will include hepatic and peripheral insulin action as well as any alterations in hepaticglucose homeostasis identified in Aim 1. 3. To test the hypothesis that metabolic phenotypes associatedwith A8 are sex-specific in the families of women with PCOS. The impact of A8 genotype on hepatic andperipheral insulin action and on insulin secretion will be examined in the brothers of women with PCOS andin age, weight and ethnicity comparable control men. Since hyperandrogenemia appears to be a finalcommon path to the female reproductive phenotype, elucidating the mechanisms for its association withmetabolic defects will be relevant to understanding diverse causes of PCOS as well as an important riskfactor for type 2 diabetes.
Showing the most recent 10 out of 123 publications
